On Dec 8, 2018 AC Immune SA (NASDAQ:ACIU) Shorts Rose By 0.88%

Change of 0.88% for AC Immune SA (NASDAQ:ACIU)’s shares shorted was reported. In December was announced ACIU’s total 1.41M shares shorted by FINRA. The 1.39 million previous shares are up with 0.88%. Former ACIU’s position will need 9 days to recover. It has 153,000 average volume. AC Immune SA’s shares shorted float is 4.26%.

Ticker’s shares touched $11.15 during the last trading session after 4.60% change.Currently AC Immune SA is downtrending after 19.43% change in last December 8, 2017. ACIU has 76,957 shares volume. The stock underperformed the S&P500 by 35.05%.

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops therapeutic and diagnostic products for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.The firm is valued at $751.09 million. The Company’s SupraAntigen and Morphomer platforms generates antibodies and small molecules that selectively bind to misfolded proteins to address neurodegenerative indications, such as AlzheimerÂ’s , ParkinsonÂ’s, down syndrome, and glaucoma diseases.Last it reported negative earnings. The companyÂ’s lead product candidate is crenezumab, a humanized, monoclonal, and conformation-specific anti-Abeta antibody, which is in Phase 3 clinical studies.

For more AC Immune SA (NASDAQ:ACIU) news brought out briefly go to: Seekingalpha.com, Globenewswire.com, Globenewswire.com, Globenewswire.com or Seekingalpha.com. The titles are as follows: “For $300M, Biogen Beefs Up Its Alzheimer’s Attack – Seeking Alpha” brought out on April 18, 2017, “AC Immune Reports Third Quarter 2018 Financial Results and Corporate Update – GlobeNewswire” on November 13, 2018, “AC Immune Shares Insights from Key Opinion Leader Meeting on Abeta Oligomers in Alzheimer’s Disease (AD) and Other Misfolded Proteins in AD and Neurodegenerative Diseases – GlobeNewswire” with a publish date: November 09, 2018, “AC Immune Announces Dr. Andreas Muhs, Chief Scientific Officer, to Take Medical Leave of Absence – GlobeNewswire” and the last “U.S. IPO Weekly Recap: Another Unicorn Takes Flight As Zuora Pops +47% – Seeking Alpha” with publication date: April 14, 2018.

AC Immune SA (NASDAQ:ACIU) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.